CM Wealth Advisors’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

CM Wealth Advisors’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-16,308	Closed	-$81K	–	464
2023 Q1	$81K	Buy	+16,308	New	+$84.6K	0.02%	401

Other funds holding CTIC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

CM Wealth Advisors's CTIC Position: Q2 2023 in Review

CM Wealth Advisors sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 16,308 shares — an estimated $81K sold.

CM Wealth Advisors first reported a position in CTIC in Q1 2023 and held it in 1 quarter. The position peaked at $81K in Q1 2023. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.

CM Wealth Advisors reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
CM Wealth Advisors sold 16,308 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $81K.
CM Wealth Advisors first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q1 2023 and held it in 1 quarter.
CM Wealth Advisors's CTI BioPharma Corp. (DE) Common Stock position peaked at $81K in Q1 2023.
2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.

Based on CM Wealth Advisors's 13F filing for Q2 2023, filed 15 Aug 2023.